This is the authors' abstract. We don't add key points for this paper.
Involvement of an α,α-cyclopropanated amino acid in the chiral Ni(II) coordination environment in the form of a Schiff-base is considered as a route to electrochemical broadening of the DA-cyclopropane concept in combination with chirality induction in the targeted products. A tendency to the reductive ring-opening and the follow-up reaction paths of thus formed radical-anions influenced by substituents in the cyclopropane ring are discussed. Optimization of the reaction conditions opens a route to the non-proteinogenic amino acid derivatives containing the α-β or β-γ double C=C bond in the side chain; the regioselectivity can be tuned by Lewis acids addition. One-pot combination of the reductive ring opening and subsequent addition of thiols allows obtaining the cysteine derivatives in practical yields and with high stereoselectivity at the removed β-stereocenter.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Levitskiy et al. (2022) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: